Mariotto, Sara
 Distribuzione geografica
Continente #
NA - Nord America 2.593
EU - Europa 1.962
AS - Asia 883
OC - Oceania 23
SA - Sud America 10
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.476
Nazione #
US - Stati Uniti d'America 2.588
CN - Cina 757
GB - Regno Unito 443
IE - Irlanda 298
IT - Italia 298
SE - Svezia 284
FR - Francia 257
DE - Germania 174
FI - Finlandia 78
VN - Vietnam 60
BE - Belgio 46
UA - Ucraina 29
RU - Federazione Russa 25
IR - Iran 23
AU - Australia 22
IN - India 15
HK - Hong Kong 10
ES - Italia 8
JP - Giappone 6
NL - Olanda 5
CA - Canada 4
CL - Cile 4
LU - Lussemburgo 4
RO - Romania 4
AR - Argentina 3
BR - Brasile 3
AT - Austria 2
KR - Corea 2
SG - Singapore 2
TW - Taiwan 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 5.476
Città #
Chandler 674
Southend 403
Dublin 284
Ashburn 240
Beijing 190
Woodbridge 145
Jacksonville 127
Verona 116
New York 99
Lawrence 96
Princeton 96
Ann Arbor 93
Wilmington 83
Jinan 69
Dearborn 66
Houston 55
Shenyang 54
Redmond 53
Sindelfingen 52
Nanjing 51
Brussels 46
Helsinki 44
Hebei 43
Washington 37
Dong Ket 36
Tianjin 28
Ningbo 27
Seattle 27
Hangzhou 22
Adelaide 21
Changsha 21
Falls Church 21
Guangzhou 20
Nanchang 20
Zhengzhou 19
Taiyuan 18
Haikou 17
Milan 17
Redwood City 16
Bologna 15
Norwalk 15
Taizhou 14
Bloomsbury 13
Chicago 12
Fairfield 11
Menlo Park 11
Dongguan 10
Jiaxing 10
Lanzhou 9
Lappeenranta 9
Hefei 8
Hong Kong 8
Lancaster 8
Fuzhou 7
Valencia 7
Boydton 6
Clearwater 6
San Diego 6
Udine 6
Bussolengo 5
Cambridge 5
Paris 5
Phoenix 5
Yicheng 5
Brescia 4
Cagliari 4
Catanzaro 4
Düsseldorf 4
Tappahannock 4
Bari 3
Boardman 3
Buenos Aires 3
Edinburgh 3
Florence 3
Frankfurt am Main 3
Hyderabad 3
Riva 3
San Francisco 3
Sant'Ambrogio di Valpolicella 3
Ardabil 2
Bochum 2
Büdelsdorf 2
Changle 2
Chaoyang 2
Chennai 2
Cursi 2
Delhi 2
Dronten 2
Freiburg im Breisgau 2
Furuichiba 2
Genova 2
Göttingen 2
Irving 2
Kochi 2
Lusaka 2
Montréal 2
Novokuznetsk 2
Padova 2
Pordenone 2
Putney 2
Totale 3.854
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 134
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 118
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 109
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 106
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 104
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 101
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 101
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 98
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 91
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 88
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 88
HCV-related nervous system disorders. 86
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 84
Brentuximab vedotin: axonal microtubule's Apollyon 81
l-dopa-induced off: functional overlay in Parkinson disease 78
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 78
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 75
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 74
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 72
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 71
Cerebrospinal fluid analysis and the determination of oligoclonal bands 70
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 67
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 67
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 66
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 66
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 65
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 65
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 63
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 63
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 61
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 61
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 61
Infectious neuropathies 60
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 59
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 59
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 59
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 58
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 57
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 57
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 55
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 55
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 54
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 53
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 52
Diagnostics of dysimmune peripheral neuropathies 52
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 52
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 52
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 52
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 52
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 52
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 51
Nervous system: subclinical target of SARS-CoV-2 infection 51
Gender disparity in editorial boards of journals in neurology 51
Inter-center agreement in the interpretation of oligoclonal bands 51
HCV-related central and peripheral nervous system demyelinating disorders. 50
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 50
Diagnostics of paraneoplastic neurological syndromes 49
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 49
Diagnostics of anti-MAG antibody polyneuropathy 47
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases 46
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 46
Autoimmune encephalitis: a retrospective monocentric experience 46
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 46
Exposure to TNF inhibitors is rare at MOGAD presentation 45
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 44
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 43
Anti-MOG-associated demyelinating disorders: two sides of the same coin 43
Oligoclonal bands: clinical utility and interpretation cues 43
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 41
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 40
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 40
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 40
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 39
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 39
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 39
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 39
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 38
Serum neurofilament light chain studies in neurological disorders, hints for interpretation 37
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study 37
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 36
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 36
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 31
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 31
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 30
Differential binding of autoantibodies to MOG isoforms in inflammatory demyelinating diseases 29
Is there a correlation between MOGAD and SARS-CoV-2 infection? 29
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation 28
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 28
Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers 27
Peripheral neuropathy and central nervous system involvement in cryoglobulinemia 27
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin 27
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 27
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 27
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 25
COVID-19 impact on consecutive neurological patients admitted to the emergency department 25
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 21
Scientific productivity in neurology: impact of the socio-economic status 20
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 19
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 19
Autoimmune encephalitis misdiagnosis and mimics 17
Totale 5.441
Categoria #
all - tutte 20.927
article - articoli 20.434
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 173
patent - brevetti 0
selected - selezionate 0
volume - volumi 320
Totale 41.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 5 14 11 8
2019/2020570 49 2 3 16 105 54 121 14 28 67 39 72
2020/2021679 124 74 32 81 67 61 27 17 45 9 73 69
2021/2022839 54 260 2 114 19 32 14 36 31 37 70 170
2022/20231.916 112 186 156 334 141 458 27 133 229 37 62 41
2023/2024992 51 81 143 145 128 299 55 76 14 0 0 0
Totale 5.707